- Home
- EVAX vs IRIX Comparison
EVAX vs IRIX Comparison
Compare EVAX & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- IRIX
- Stock Information
- Founded
- EVAX 2008
- IRIX 1989
- Country
- EVAX Denmark
- IRIX United States
- Employees
- EVAX N/A
- IRIX N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EVAX Health Care
- IRIX Health Care
- Exchange
- EVAX Nasdaq
- IRIX Nasdaq
- Market Cap
- EVAX 15.1M
- IRIX 16.5M
- IPO Year
- EVAX 2021
- IRIX 1996
- Fundamental
- Price
- EVAX $2.64
- IRIX $1.01
- Analyst Decision
- EVAX Strong Buy
- IRIX
- Analyst Count
- EVAX 2
- IRIX 0
- Target Price
- EVAX $10.00
- IRIX N/A
- AVG Volume (30 Days)
- EVAX 101.0K
- IRIX 66.5K
- Earning Date
- EVAX 08-13-2025
- IRIX 08-07-2025
- Dividend Yield
- EVAX N/A
- IRIX N/A
- EPS Growth
- EVAX N/A
- IRIX N/A
- EPS
- EVAX N/A
- IRIX N/A
- Revenue
- EVAX $3,293,000.00
- IRIX $48,804,000.00
- Revenue This Year
- EVAX N/A
- IRIX $9.61
- Revenue Next Year
- EVAX N/A
- IRIX N/A
- P/E Ratio
- EVAX N/A
- IRIX N/A
- Revenue Growth
- EVAX 2555.64
- IRIX N/A
- 52 Week Low
- EVAX $1.20
- IRIX $0.78
- 52 Week High
- EVAX $17.75
- IRIX $2.41
- Technical
- Relative Strength Index (RSI)
- EVAX 55.56
- IRIX 61.37
- Support Level
- EVAX $2.26
- IRIX $0.92
- Resistance Level
- EVAX $2.60
- IRIX $1.01
- Average True Range (ATR)
- EVAX 0.21
- IRIX 0.05
- MACD
- EVAX -0.02
- IRIX 0.02
- Stochastic Oscillator
- EVAX 51.32
- IRIX 100.00
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.